Completed OBSERVATIONAL NCT01754311

Influence of IL28B Genetic Variation on the Phenotype Infection of HTLV-1 (HAMIL28B)

Sponsor: Laboratoire Cerba

Updated 7 times since 2017 Last updated: Mar 19, 2018 Started: May 13, 2013 Primary completion: Jun 24, 2014 Completion: Jun 24, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on HTLV-I Infections, this trial is completed. The trial is conducted by Laboratoire Cerba and has accumulated 7 data snapshots since 2013. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Completed

Status: Unknown Status → Completed · Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Unknown Status NA

First recorded

May 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Laboratoire Cerba
University Hospital Center of Martinique

Data source: University Hospital Center of Martinique

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Fort-de-France, Martinique